1629160 - gene synthesis/ plasmid preparation
Ended Purchase Order Awarded
- Contract number
- HHSN272201300444P
- Awardee
-
Genscript USA Inc. UEI KVLBRRAQ6UX1
- Awarding agency
-
NIAID DEA OA Acquisitions
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,343
Award facts
- Contract value 100% obligated
- $4,342.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,342.69 firm fixed-price purchase order was awarded to Genscript USA Inc., a biotechnology company based in New Jersey, for gene synthesis and plasmid preparation services. The contract did not have a set-aside designation.
Genscript has received numerous prime and subcontract awards from HHS agencies, including NIH, the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), as well as the U.S. Department of Agriculture (USDA), to provide a variety of molecular biology products and services in support of biomedical research and public health initiatives. This includes supplying customized DNA constructs, antibodies, proteins, peptides, cell lines, and related materials for vaccine development, therapeutic antibody research, diagnostic assay creation, and other R&D efforts targeting emerging infectious diseases like COVID-19, influenza, HIV, and Ebola.
The award references a larger blanket purchase agreement (BPA) that Genscript holds with USDA's Animal and Plant Health Inspection Service (APHIS), valued at up to $1.5 million through 2024, to provide SARS-CoV-2 surrogate virus neutralization test kits and associated reagents in support of USDA's animal disease monitoring and research initiatives.
Quick answers
Who was awarded contract HHSN272201300444P?
HHSN272201300444P was awarded to Genscript USA Inc. by NIAID DEA OA Acquisitions (National Institutes of Health) on April 24, 2013.
How much is contract HHSN272201300444P worth?
The government has obligated $4,343 on HHSN272201300444P.
Was contract HHSN272201300444P competed?
The extent of competition for HHSN272201300444P was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award